Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-04-27

Clinical Trial Update: Itch Relieving Effect of Botox: a Study in Healthy Subjects [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 clinical trial examines whether Botox (onabotulinumtoxinA) relieves itch in healthy subjects, with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Botox (OnabotulinumtoxinA)

Snippet

Sponsor: Temple University | Conditions: Pruritus | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2017-04-27